Nebius stock fell 4.06% to $248.68 after a sharp 34.14% gain fueled by its impressive Q2 earnings report. The company reported a 454% revenue increase to $582 million, beating forecasts, and narrowed its loss per share by 68%. Despite strong growth and a $3 billion annualized run rate, concerns remain over high capital expenditures, ongoing losses, and concentrated AI demand from a few companies. The results helped revive interest in AI stocks but future volatility is possible amid sector challenges.
Equity markets continue to rise driven by optimism around AI, with companies like CoreWeave and Nebius posting strong quarterly results. However, credit markets are showing signs of increasing stress, particularly in private credit and commercial rea...
President Trump's executive order to separate the combined MMR vaccine into individual shots faces significant regulatory and manufacturing challenges, with FDA approval potentially taking up to 10 years. Merck and GSK, the only licensed producers of...
Nebius exceeded expectations in its Q2 earnings, driven by rapid growth in its cloud computing base and high demand for GPUs. The company raised its cloud capacity forecast for the current fiscal year by 25% to 5 GW, signaling strong expansion. Nebiu...
Nebius shares surged 34% following a quarterly report showing a 454% revenue increase to $582 million and a reduced loss per share of $0.12. This strong performance led several analysts, including those from Bank of America and Baird, to raise their ...
CoreWeave (CRWV) is rated Buy, favored for its larger scale, lower reliance on prepayment funding, and stronger cash flow, which reduce cash burn and improve return on invested capital compared to Nebius (NBIS), rated Sell. Although Nebius trades at ...
